Trailing-twelve-month (TTM) revenue is $780.97 Million with a year-over-year growth of (16.71%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $175,481,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $181,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $241,571,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $182,918,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $780,970,000 |
Current P/S: $3,835,697,572 market capitalization ÷ $780,970,000 TTM revenue = 4.91x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:24:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $182.92M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:45:40.549Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Deposit Account | $77M | $74M | $83M | $77M | $70M | $71M |
| Fiduciary and Trust | N/A | N/A | $13M |
$780.97M
$780.97 Million
(16.71%)
vs. $937.65M a year ago (TTM)
+10.17%
5 Year compound annual growth rate
1 Year
(16.71%)
3 Year
+1.84%
5 Year
+10.17%
10 Year
+9.52%
15 Year
+7.88%
20 Year
+5.91%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $824.33M | ($84.39M) | (9.29%) |
| 2024 | $908.71M | +$99.37M | +12.28% |
| 2023 | $809.34M | +$205.78M | +34.09% |
| 2022 | $603.57M | +$106.51M | +21.43% |
| 2021 | $497.05M | +$32.72M | +7.05% |
| 2020 |
TTM Growth
(16.71%)
3-Year CAGR
+1.84%
5-Year CAGR
+10.17%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $22M |
| $23M |
| Fiduciary And Trust | $14M | $13M | N/A | N/A | N/A | N/A |
|---|
| $464.34M |
| ($9.55M) |
| (2.02%) |
| 2019 | $473.89M | +$45.48M | +10.62% |
| 2018 | $428.40M | +$62.27M | +17.01% |
| 2017 | $366.14M | +$40.54M | +12.45% |
| 2016 | $325.60M | +$18.75M | +6.11% |
